CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances

SIMPLE SUMMARY: Despite intensive standard treatment, acute myeloid leukemia (AML) continues to be associated with a poor prognosis due to treatment resistance and a high risk of relapse. For this reason, it is necessary to develop new therapeutic strategies, which, when used in combination with sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarychta, Julia, Kowalczyk, Adrian, Krawczyk, Milena, Lejman, Monika, Zawitkowska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252035/
https://www.ncbi.nlm.nih.gov/pubmed/37296906
http://dx.doi.org/10.3390/cancers15112944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252035/
https://www.ncbi.nlm.nih.gov/pubmed/37296906
http://dx.doi.org/10.3390/cancers15112944

Ejemplares similares